INTERNATIONAL PATENT: CYTOKINETICS, INCORPORATED FILES APPLICATION FOR "OMECAMTIV MECARBIL FOR USE IN TREATING HEART FAILURE BY ACTIVATING CARDIAC SARCOMERE"

GENEVA, March 11 -- CYTOKINETICS, INCORPORATED (350 Oyster Point Blvd.South San Franciso, California 94080) filed a patent application (PCT/US2025/043937) for "OMECAMTIV MECARBIL FOR USE IN TREATING HEART FAILURE BY ACTIVATING CARDIAC SARCOMERE" on Aug 28, 2025. With publication no. WO/2026/050494, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MALIK, Fady (c/o Cytokinetics, Incorporated350 Oyster Point Blvd.South San Francisco, California 94080), KUPFER, Stuart (c/o Cytokinetics, Incorporated350 Oyster Point Blvd.South ...